首页 | 本学科首页   官方微博 | 高级检索  
     

4种慢性乙型肝炎治疗方案的成本-效果分析
引用本文:劳国琴,唐志华,王佳良. 4种慢性乙型肝炎治疗方案的成本-效果分析[J]. 药学实践杂志, 2004, 22(6): 374-376
作者姓名:劳国琴  唐志华  王佳良
作者单位:1. 浙江省绍兴市第六人民医院
2. 浙江省绍兴市人民医院,浙江,绍兴,312000
摘    要:目的:探讨不同药物治疗方案对同一种疾病所产生的效果。方法:运用药物经济学成本-效果分析方法对4种慢性乙型肝炎治疗方案(A-苦参素注射液、B-拉米夫定 胸腺肽、C-干扰素、D-拉米夫定)进行回顾性分析评价。结果:4种方案的有效率分别为74.14%、91.25%、82.86%、83.33%;不良反应发生率分别为12.07%、8.75%、38.57%、1.39%;成本-效果比分别为88.83、134.89、174.11、91.03。结论:D方案为最佳治疗方案。

关 键 词:药物经济学  成本-效果分析  慢性乙型肝炎
文章编号:1006-0111(2004)06-0374-03
收稿时间:2004-06-15
修稿时间:2004-06-15

Cost-effectiveness analysis of 4 therapeutic schemes for chronic hepatitis B
LAO Guo-qin,TANG Zhi-hua and WANG Jia-liang. Cost-effectiveness analysis of 4 therapeutic schemes for chronic hepatitis B[J]. The Journal of Pharmaceutical Practice, 2004, 22(6): 374-376
Authors:LAO Guo-qin  TANG Zhi-hua  WANG Jia-liang
Affiliation:Shaoxing Sixth Hospital;Shaoxing People's Hospital, Shaoxing 312000, China;Shaoxing Sixth Hospital
Abstract:Objective:To evaluate the economic effectiveness of different drug therapeutic schemes for the same disease. Methods: Using pharmacoeconomical cost-effectiveness analysis,four therapeutic schemes for chronic hepatitis B ( A-alkoloids sophora injection, B-lamivudine thymosin, C-interferon, D-lamivudine) were compared. Results: The effective rates of four groups were 74. 14% , 91. 25% ,82. 86% and 83. 33% respectively; The adverse drug reaction rates were 12. 07% ,8. 75% ,38. 57% and 1. 39% . And the cost - effectiveness ratios were respectively 88. 83 ,134. 89,174. 11 and 91. 03. Conclusion:Schemes D are the best one.
Keywords:pharmacoeconomics  cost-effect analysis  chronic hepatitis B
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《药学实践杂志》浏览原始摘要信息
点击此处可从《药学实践杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号